Survival after large ABO-incompatible blood transfusion.
Ti
L K
LK
Ang
S B
SB
Chen
F G
FG
D000017:ABO Blood-Group System / Q000009:adverse effects*; D058186:Acute Kidney Injury / Q000517:prevention & control; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001788:Blood Grouping and Crossmatching; D002315:Cardiopulmonary Bypass; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002675:Child, Preschool; D004211:Disseminated Intravascular Coagulation / Q000517:prevention & control; D004232:Diuretics / Q000627:therapeutic use; D004298:Dopamine / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006461:Hemolysis; D006648:Histocompatibility; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D013534:Survival; D065227:Transfusion Reaction
D000017:ABO Blood-Group System; D000893:Anti-Inflammatory Agents; D002316:Cardiotonic Agents; D004232:Diuretics; D005665:Furosemide; D004298:Dopamine; D006854:Hydrocortisone